1. Home
  2. YHC vs BDRX Comparison

YHC vs BDRX Comparison

Compare YHC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$1.59

Market Cap

2.3M

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$1.60

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
BDRX
Founded
2021
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.2M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
YHC
BDRX
Price
$1.59
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
232.7K
41.9K
Earning Date
04-15-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,120,622.00
N/A
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
86.42
N/A
52 Week Low
$0.02
$0.60
52 Week High
$2.72
$11.88

Technical Indicators

Market Signals
Indicator
YHC
BDRX
Relative Strength Index (RSI) 51.36 37.74
Support Level $0.72 $1.03
Resistance Level $2.20 $3.68
Average True Range (ATR) 0.26 0.22
MACD -0.05 0.05
Stochastic Oscillator 41.48 67.43

Price Performance

Historical Comparison
YHC
BDRX

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: